Annual Drug Patent Expiration for XPOVIO
Xpovio is a drug marketed by Karyopharm Theraps and included in one NDA. It is available from a single supplier. There are six patents protecting this drug.
This drug has one hundred and ten patent family members in thirty-seven countries.
The generic ingredient in XPOVIO is selinexor. One registered supplier for this compound. Additional details are available on the selinexor profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Karyopharm Theraps XPOVIO